MAM
DBTX

Marquette Asset Management’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Marquette Asset Management’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,783
Closed -$59.7K – 306
2023
Q1 		$59.7K Hold
19,783
– – 0.02% 140
2022
Q4 		$40.6K Hold
19,783
– – 0.01% 159
2022
Q3 		$68K Sell
19,783
-5,921
-23% -$26.9K 0.02% 127
2022
Q2 		$108K Hold
25,704
– – 0.03% 123
2022
Q1 		$78K Buy
25,704
+7,232
+39% +$27.7K 0.02% 165
2021
Q4 		$86K Buy
+18,472
New +$127K 0.02% 160

Other funds holding DBTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Marquette Asset Management's DBTX Position: Q2 2023 in Review

Marquette Asset Management sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q2 2023, closing a stake of 19,783 shares — an estimated $59.7K sold.

Marquette Asset Management first reported a position in DBTX in Q4 2021 and held it in 6 quarters. The position peaked at $108K in Q2 2022. 37 funds tracked by Wall St. Rank hold DBTX as of Q2 2023.

  • Marquette Asset Management reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Marquette Asset Management sold 19,783 Decibel Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $59.7K.
  • Marquette Asset Management first reported a position in Decibel Therapeutics, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Marquette Asset Management's Decibel Therapeutics, Inc. Common Stock position peaked at $108K in Q2 2022.
  • 37 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Marquette Asset Management's 13F filing for Q2 2023, filed 28 Jul 2023.